84 related articles for article (PubMed ID: 34412054)
21. The efficacy and safety of low-dose Apatinib in the management of stage IV luminal-type breast cancer: a case report and literature review.
Lv X; Chen J; Yi T; Lu H; Liu J; Yu D
Anticancer Drugs; 2021 Sep; 32(8):773-778. PubMed ID: 34145174
[TBL] [Abstract][Full Text] [Related]
22. Modulation of hypoxia-inducible factor-1 signaling pathways in cancer angiogenesis, invasion, and metastasis by natural compounds: a comprehensive and critical review.
Fakhri S; Moradi SZ; Faraji F; Kooshki L; Webber K; Bishayee A
Cancer Metastasis Rev; 2024 Mar; 43(1):501-574. PubMed ID: 37792223
[TBL] [Abstract][Full Text] [Related]
23. Isoimperatorin Inhibits Angiogenesis by Suppressing VEGFR2 Signaling Pathway.
Xu Y; Xia D; Deng S; Liang M
Cardiovasc Drugs Ther; 2024 Feb; ():. PubMed ID: 38363479
[TBL] [Abstract][Full Text] [Related]
24. The inhibitory effect of apatinib on different small cell lung cancer cells and in lung cancer-bearing mice and patients.
Liu M; Li H; Guo R; Yu X; Li Y
Clin Respir J; 2024 Feb; 18(2):e13738. PubMed ID: 38403875
[TBL] [Abstract][Full Text] [Related]
25. Apatinib weakens proliferation, migration, invasion, and angiogenesis of thyroid cancer cells through downregulating pyruvate kinase M2.
Yang X; Li W; Han X; Wang J; Dai J; Ye X; Meng M
Sci Rep; 2024 Jan; 14(1):879. PubMed ID: 38195651
[TBL] [Abstract][Full Text] [Related]
26. Molecular MRI assessment of vascular endothelial growth factor receptor-2 in rat C6 gliomas.
He T; Smith N; Saunders D; Doblas S; Watanabe Y; Hoyle J; Silasi-Mansat R; Lupu F; Lerner M; Brackett DJ; Towner RA
J Cell Mol Med; 2011 Apr; 15(4):837-49. PubMed ID: 20497492
[TBL] [Abstract][Full Text] [Related]
27. KSCBi005-A-10(hiPSC-HIF1αKO), a HIF1α knockout human induced pluripotent stem cell line, for demonstrating the role of cellular response to hypoxia.
Han HJ; Kim JH
Stem Cell Res; 2024 Apr; 77():103415. PubMed ID: 38636267
[TBL] [Abstract][Full Text] [Related]
28. Gastric cancer secreted miR-214-3p inhibits the anti-angiogenesis effect of apatinib by suppressing ferroptosis in vascular endothelial cells.
Wang W; Wang T; Zhang Y; Deng T; Zhang H; Ba YI
Oncol Res; 2024; 32(3):489-502. PubMed ID: 38370339
[TBL] [Abstract][Full Text] [Related]
29. Expression and association of vascular endothelial growth factor, vascular endothelial growth factor receptor, and phosphorylated signal transducer and activator of transcription factor 3 in malignant gliomas.
Edura P; Vokuda R; Ramamoorthi S; Srinivas BH; Verma SK; Sasidharan G
J Neurosci Rural Pract; 2023; 14(4):723-728. PubMed ID: 38059258
[TBL] [Abstract][Full Text] [Related]
30. A Synergistic Combination of Oleanolic Acid and Apatinib to Enhance Antitumor Effect on Liver Cancer Cells and Protect against Hepatic Injury.
Ren J; Yan J; Raza F; Zafar H; Wan H; Chen X; Cui Q; Li H; Wang X
Recent Pat Anticancer Drug Discov; 2024; 19(2):199-208. PubMed ID: 38214359
[TBL] [Abstract][Full Text] [Related]
31. Ubiquitination of basal VEGFR2 regulates signal transduction and endothelial function.
Smith GA; Fearnley GW; Abdul-Zani I; Wheatcroft SB; Tomlinson DC; Harrison MA; Ponnambalam S
Biol Open; 2017 Oct; 6(10):1404-1415. PubMed ID: 28798148
[TBL] [Abstract][Full Text] [Related]
32. Radioactive
Luo J; Zheng J; Yao H; Wang B; Zhang Z; Shao G
Dose Response; 2023; 21(3):15593258231187348. PubMed ID: 37424703
[TBL] [Abstract][Full Text] [Related]
33. PF-2341066 combined with celecoxib promotes apoptosis and inhibits proliferation in human cholangiocarcinoma QBC939 cells.
Chen C; Yang D; Zeng Q; Luo L; Cai C
Exp Ther Med; 2018 May; 15(5):4543-4549. PubMed ID: 29725387
[TBL] [Abstract][Full Text] [Related]
34. Clinical advances in the development of novel VEGFR2 inhibitors.
Fontanella C; Ongaro E; Bolzonello S; Guardascione M; Fasola G; Aprile G
Ann Transl Med; 2014 Dec; 2(12):123. PubMed ID: 25568876
[TBL] [Abstract][Full Text] [Related]
35. Protective effect of cilostazol on vascular injury in rats with acute ischemic stroke complicated with chronic renal failure.
Sun R; Gu Q; Zhang X; Zeng R; Chen D; Yao J; Min J
Toxicol Res; 2024 Apr; 40(2):189-202. PubMed ID: 38525134
[TBL] [Abstract][Full Text] [Related]
36. Apatinib combined with concurrent chemoradiotherapy in patients with subglottic small cell carcinoma: a case report.
Chen M; Wu S; He Z; Cheng Z; Duan S; Jiang H; Wang G
J Int Med Res; 2021 May; 49(5):3000605211016146. PubMed ID: 34038201
[TBL] [Abstract][Full Text] [Related]
37. miR-130a activates the VEGFR2/STAT3/HIF1α axis to potentiate the vasoregenerative capacity of endothelial colony-forming cells in hypoxia.
Guduric-Fuchs J; Pedrini E; Lechner J; Chambers SEJ; O'Neill CL; Mendes Lopes de Melo J; Pathak V; Church RH; McKeown S; Bojdo J; Mcloughlin KJ; Stitt AW; Medina RJ
Mol Ther Nucleic Acids; 2021 Mar; 23():968-981. PubMed ID: 33614244
[TBL] [Abstract][Full Text] [Related]
38. Stylopine: A potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy.
Velayutham NK; Thamaraikani T; Wahab S; Khalid M; Ramachawolran G; Abullais SS; Wong LS; Sekar M; Gan SH; Ebenezer AJ; Ravikumar M; Subramaniyan V; Mat Rani NNI; Wu YS; Jeyabalan S
Front Pharmacol; 2023; 14():1150270. PubMed ID: 37056983
[TBL] [Abstract][Full Text] [Related]
39. Apatinib induces zebrafish hepatotoxicity by inhibiting Wnt signaling and accumulation of oxidative stress.
Huang L; Wang Z; Liu J; Wan M; Liu J; Liu F; Tu X; Xiao J; Liao X; Lu H; Zhang S; Cao Z
Environ Toxicol; 2023 Nov; 38(11):2679-2690. PubMed ID: 37551640
[TBL] [Abstract][Full Text] [Related]
40. Treatment of cholangiocarcinoma by pGCsiRNA-vascular endothelial growth factor in vivo.
Lu S; Li J
Asian Biomed (Res Rev News); 2024 Apr; 18(2):61-68. PubMed ID: 38708333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
